Abivax says JPMorgan beneficial stake rises to 5.46% voting rights, 4,460,843 shares

Jpmorgan Chase
Abivax SA Sponsored ADR

Jpmorgan Chase

JPM

0.00

Abivax SA Sponsored ADR

ABVX

0.00
  • JPMorgan Chase disclosed it indirectly held 4,460,843 shares in Abivax on May 18, representing 5.63% of share capital and 5.46% of voting rights.
  • The stake moved back above the 5% voting-rights threshold three days after JPMorgan reported a drop below it on May 15.
  • On May 15, JPMorgan reported 4,024,789 shares, equal to 5.08% of share capital and 4.93% of voting rights.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.